000 01259 a2200373 4500
005 20250517120153.0
264 0 _c20170224
008 201702s 0 0 eng d
022 _a1521-0464
024 7 _a10.1080/10717544.2016.1212441
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSutton, J T
245 0 0 _aDelivery of bevacizumab to atheromatous porcine carotid tissue using echogenic liposomes.
_h[electronic resource]
260 _bDrug delivery
_cNov 2016
300 _a3594-3605 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAngiogenesis Inhibitors
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aBevacizumab
_xadministration & dosage
650 0 4 _aLiposomes
_xchemistry
650 0 4 _aSwine
650 0 4 _aUltrasonics
_xmethods
650 0 4 _aVascular Endothelial Growth Factor A
_xmetabolism
700 1 _aHaworth, K J
700 1 _aShanmukhappa, S K
700 1 _aMoody, M R
700 1 _aKlegerman, M E
700 1 _aGriffin, J K
700 1 _aPatton, D M
700 1 _aMcPherson, D D
700 1 _aHolland, C K
773 0 _tDrug delivery
_gvol. 23
_gno. 9
_gp. 3594-3605
856 4 0 _uhttps://doi.org/10.1080/10717544.2016.1212441
_zAvailable from publisher's website
999 _c26472289
_d26472289